Abstract:Due to the teratogenic potential of many oral hypoglycemic agents, insulin injections are the primary treatment for diabetes in pregnant women. There has been insufficient study of insulin glargine in pregnancy. Therefore, NPH insulin continues to be the primary basal insulin used in pregnancies. The insulin requirement rises substantially in the second and third trimesters. NPH insulin and rapid-acting insulin are mixed typically in a 1:1 ratio and administered at each main meal. The insulin pump is a viable … Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.